Expert Perspectives on a 75-Year-Old Woman With Relapsed/Refractory Follicular Lymphoma

Loretta Nastoupil, MD, reviews the case of a 75-year-old woman with relapsed/refractory follicular lymphoma (R/R FL).

Loretta Nastoupil, MD, describes the role of molecular testing used in risk stratification of patient with FL

Loretta Nastoupil, MD, discusses first-line therapy options for patients with newly diagnosed follicular lymphoma (ND FL).

A key opinion leader in the treatment of FL provides insight on the decision of whether to add maintenance therapy to the treatment regimen.

Loretta Nastoupil, MD, describes the challenges of selecting treatment beyond the second-line.

Loretta Nastoupil, MD, describes the challenges of selecting treatment beyond the second-line.

Loretta Nastoupil, MD, discusses the use of tazemetostat in patients with and without an EZH2m.

Dr Loretta Nastoupil describes best practices for managing the side effects of tazemetostat in patients with R/R FL.

Looking ahead, Loretta Nastoupil, MD, reviews the future direction and unmet needs in the management of relapsed/refractory follicular lymphoma (R/R FL).